AstraZeneca PLC - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AZN Nasdaq 2830 www.astrazeneca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca PLC

AstraZeneca Stock Scores RS Rating Upgrade - Mar 14th, 2025 8:02 pm
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants - Mar 14th, 2025 5:39 pm
AstraZeneca director says AI must be a “thought partner” in drug discovery - Mar 14th, 2025 5:29 pm
AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer - Mar 14th, 2025 4:00 pm
AstraZeneca Stock Nears Buy Point After Long Run In Declining Market - Mar 13th, 2025 3:55 pm
Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report? - Mar 13th, 2025 3:30 pm
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know - Mar 12th, 2025 10:15 pm
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion - Mar 12th, 2025 8:09 pm
IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe - Mar 11th, 2025 12:43 pm
AstraZeneca and Ionis win EU approval for ATTR polyneuropathy - Mar 10th, 2025 11:18 pm
AstraZeneca reports positive outcomes from trial of Imfinzi - Mar 10th, 2025 10:04 am
AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients - Mar 7th, 2025 12:54 pm
IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers - Mar 7th, 2025 12:00 pm
Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know - Mar 6th, 2025 11:15 pm
Is AstraZeneca PLC (LON:AZN) Trading At A 45% Discount? - Mar 6th, 2025 7:19 am
What Trump's next batch of tariffs could mean for pharma industry - Mar 5th, 2025 2:45 pm
Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Mar 5th, 2025 7:04 am
EU set to approve AstraZeneca’s Imfinzi-chemo combo for NSCLC - Mar 4th, 2025 11:49 am
Daiichi Sankyo and AstraZeneca’s Enhertu shows OS improvements in Phase III trial - Mar 4th, 2025 10:30 am
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP - Mar 3rd, 2025 12:44 pm